Raia Drogasil (OTCMKTS:RADLY) Stock Price Up 14.1% – What’s Next?

Raia Drogasil S.A. (OTCMKTS:RADLY)’s stock price was up 14.1% on Tuesday. The company traded as high as $4.3370 and last traded at $4.3350. 3,693 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 86,805 shares. The stock had previously closed at $3.80.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group upgraded shares of Raia Drogasil to a “buy” rating and set a $5.20 price objective on the stock in a research note on Sunday. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $5.20.

Raia Drogasil Stock Performance

The firm’s 50-day moving average price is $3.78 and its two-hundred day moving average price is $3.85. The firm has a market capitalization of $5.43 billion and a PE ratio of 25.82. The company has a quick ratio of 0.58, a current ratio of 1.41 and a debt-to-equity ratio of 0.99.

Raia Drogasil (OTCMKTS:RADLY) last issued its earnings results on Tuesday, August 4th. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. Raia Drogasil had a return on equity of 20.12% and a net margin of 2.99%. The business had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.32 billion. As a group, research analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a network of pharmacies offering prescription medicines, over-the-counter drugs, vitamins, personal care products, beauty items and other health-related merchandise.

The company also provides digital purchasing and delivery services through its online channels, supporting customers with prescription fulfillment, health products and related services. Its operations include pharmacy-based healthcare initiatives designed to complement its retail business and improve access to everyday healthcare.

RD Saúde was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains.